Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03367689
Title A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications

breast cancer

Therapies

Olaparib

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.